乳腺超声检出的非肿块病变:癌症风险分层以指导临床管理
结论认为该分类系统整合超声和钼靶特征,有助于依据BI-RADS类别对超声检出的非肿块病变进行风险分层和临床管理。
要点
- 超声检出非肿块病变的可疑B模式特征包括:节段性分布、伴异常导管改变、钙化、后方声影。
- 超声上可能为良性的特征是存在多个小囊肿。
- 钼靶上对应的可疑特征为伴钙化和局灶性不对称。
关键影像表现/征象
- B模式超声上,与恶性相关的特征包括:节段性分布(OR=3.03;95%CI 1.50-6.15)、伴钙化(OR=4.26;95%CI 1.62-11.18)、异常导管改变(OR=4.91;95%CI 2.07-11.68)、后方声影(OR=20.20;95%CI 6.46-63.23),均p<0.001。
- 钼靶上,与恶性相关的特征包括:钙化(OR=7.98;95%CI 3.06-20.81)和局灶性不对称(OR=4.75;95%CI 1.90-11.88),均p<0.001。
- 超声上可能为良性的特征是存在多个小囊肿。
诊断标准与关键数值
- 分类系统基于开发数据集(n=460)中与恶性显著相关的影像特征的OR值构建,用于划分BI-RADS 3至5类。
临床应用与阅片要点
- 作者认为,整合超声(联合或不联合钼靶)特征的分类系统可能用于临床实践中解读和管理超声检出的任何非肿块病变。
- 超声阅片时需关注非肿块病变的节段性分布、伴钙化、异常导管改变和后方声影等可疑特征,以及多个小囊肿这一可能良性特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a classification system using imaging features to interpret breast non-mass lesions (NMLs) detected on US and to stratify their cancer risk.
METHODS: This retrospective study included 715 patients with 715 breast NMLs detected on breast US from 2012 to 2016. Each patient underwent mammography at the time of diagnosis. Radiologists assessed US and mammographic features and final BI-RADS categories. Multivariable logistic regression was used to find imaging features associated with malignancy in a development dataset (n = 460). A system to classify BI-RADS categories (3 to 5) was developed based on the odds ratios (ORs) of imaging features significantly associated with malignancy and validated in a distinct validation dataset (n = 255).
RESULTS: Among 715 NMLs, 385 (53.8%) were benign and 330 (46.2%) were malignant. In the development dataset, the following B-mode US features were associated with malignancy (all p < 0.001): segmental distribution (OR = 3.03; 95% confidence interval [CI], 1.50-6.15), associated calcifications (OR = 4.26; 95% CI, 1.62-11.18), abnormal ductal change (OR = 4.91; 95% CI, 2.07-11.68), and posterior shadowing (OR = 20.20; 95% CI, 6.46-63.23). The following mammographic features were also associated with malignancy (all p < 0.001): calcifications (OR = 7.98; 95% CI, 3.06-20.81) and focal asymmetry (OR = 4.75; 95% CI, 1.90-11.88). In the validation dataset, our classification system using US and mammography showed a higher area under the curve (0.951-0.956) compared to when it was not applied (0.908-0911) to predict malignancy with BI-RADS categories (p < 0.05).
CONCLUSION: Our classification system which incorporates US and mammographic features of breast NMLs can help interpret and manage all NMLs detected on breast US by stratifying cancer risk according to BI-RADS categories.
KEY POINTS: • When diagnosing breast NMLs detected on US, suspicious US features are segmental distribution, associated abnormal ductal change, calcifications, and posterior shadowing within or around the NML on B-mode US, while a probably benign US feature is the presence of multiple small cysts. • Corresponding suspicious mammographic features of breast NMLs detected on US are associated calcifications and focal asymmetry. • Our classification system which incorporates US features with and without mammography can potentially be used to interpret and manage any NMLs detected on breast US in clinical practice.
引用
- Park KW, Park S, Shon I, et al. Non-mass lesions detected by breast US: stratification of cancer risk for clinical management. Eur Radiol. 2020. PMID: 32888070. doi:10.1007/s00330-020-07168-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。